Expulsion of amplified MYCN from homogenously staining chromosomal regions in neuroblastoma cell lines after cultivation with cisplatin, doxorubicin, hydroxyurea, and vincristine
Authors:
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 196 (1) , 96-104
Abstract
No abstract availableKeywords
Funding Information
- Grantová Agentura, Univerzita Karlova (7926/2007)
- Ministerstvo Školství, Mládeže a Tělovýchovy (MSM0021620813)
This publication has 18 references indexed in Scilit:
- Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyureaGenes, Chromosomes and Cancer, 2006
- The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell lineCarcinogenesis, 2004
- Chemotherapy-induced Apoptosis of S-type Neuroblastoma Cells Requires Caspase-9 and Is Augmented by CD95/Fas StimulationJournal of Biological Chemistry, 2004
- Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: A preclinical modelInternational Journal of Cancer, 2003
- In Vivo Elimination of Acentric Double Minutes Containing Amplified MYCN from Neuroblastoma Tumor Cells Through the Formation of MicronucleiThe American Journal of Pathology, 2001
- Expulsion of Amplified MYCN from Neuroblastoma Tumor CellsCancer Genetics and Cytogenetics, 2000
- Oncogene amplification in solid tumorsSeminars in Cancer Biology, 1999
- Neuroblastoma cells can actively eliminate supernumerary MYCN gene copies by micronucleus formation—sign of tumour cell revertance?European Journal of Cancer, 1997
- Effect of Cisplatin Exposure on the Degree of N-myc Amplification in Small Cell Lung Carcinoma Cell Lines with N-myc AmplificationOncology, 1996
- Different drug sensitivity in two neuroblastoma cell lines established from the same patient before and after chemotherapyInternational Journal of Cancer, 1991